Exploring GLP-1 Receptor Agonist Effects on Reward System Suppression
GLP-1 receptor agonist reward system suppression extends beyond appetite control, influencing motivation and behavioral patterns. This effect is important for clinicians to monitor in patients. Understanding these broader impacts can improve patient…
Walmart Pharmacy Expands GLP-1 Weight Loss Programs
Walmart Pharmacy has expanded its GLP-1 weight loss programs, improving patient access to these therapies. The Medicare GLP-1 Bridge program helps bridge coverage gaps for eligible patients. These retail pharmacy programs represent a shift in how…
Healthcare Agencies Mellow on Medical Cannabis as CMS Launches Medicare Hemp Pilot
The CMS hemp pilot program represents a significant federal step toward integrating cannabis therapies into Medicare. This pilot focuses on hemp-derived products and signals potential policy shifts. Healthcare agencies are closely monitoring this…
